PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17929112-5	2007	A new synthetic retinoid, tamibaroten, showed therapeutic effectiveness in patients with ATRA-resistant APL with increased expression of cellular retinoic acid binding protein (CRABP), and about 60% of patients with relapsed APL achieved a CR.	tamibaroten	26-37	cellular retinoic acid binding protein 1	Homo sapiens	137-175	
17929112-5	2007	A new synthetic retinoid, tamibaroten, showed therapeutic effectiveness in patients with ATRA-resistant APL with increased expression of cellular retinoic acid binding protein (CRABP), and about 60% of patients with relapsed APL achieved a CR.	tamibaroten	26-37	cellular retinoic acid binding protein 1	Homo sapiens	177-182